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A B S T R A C T
The authors describe a 19 year old male with an isolated but absolute erythrocytosis with iron deficiency without evi-
dence for polycythemia vera as well as another causes of erythrocytosis. The polycythemia was due to a recently described
von Hippel-Lindau (VHL) mutation. By stopping iron therapy there was no more requirements for phlebotomy in this pa-
tient.
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Introduction
Absolute polycythemia or erythrocytosis is a condi-
tion with increased red blood cell mass, and it can be ei-
ther acquired or congenital. These hematological disor-
ders are divided into primary where the erythropoietic
compartment is intrinsically abnormal, and secondary
where the erythropoietic compartment is normal but is
responding to pathologic events outside the bone mar-
row, leading to an increased erythropoietin drive. Both
primary and secondary polycythemias may be either con-
genital or acquired1. Polycythemia is rarely seen in child-
ren2,3.
Case Report
A 12-year-old white boy was admitted in June 1997
for erythrocytosis, which was detected incidentally dur-
ing an emergency room visit for a febrile illness and
headache. Prior medical history was unremarkable. The
patient had not traveled to high altitudes. There was no
family history of hematologic disease. On examination
the boy was in a very good general condition with facial
and conjunctival plethora, all other clinical findings were
within normal limits, blood pressure 110/80 mmHg. He
was without pruritus, tinnitus, or vertigo. Hemogram:
erythrocytes (E) 9.02x1012/L, hemoglobin (Hgb) 196 g/L,
hematocrit (Hct) 0.65; MCV (mean corpuscular volume)
78 fL, MCHC (mean corpuscular hemoglobin concentra-
tion) 269 g/L. White blood cell and platelet counts were
normal. Determination of the volume of erythrocytes by
Cr-51 sodium chromate: 53.3 ml/kg (N 35 ml/kg). All
causes of secondary polycythemia were eliminated by ap-
propriate investigations. Vitamin B12 and folic acid in
serum were within normal limits. Serum iron (Fe) level
was low, 8.5 µmol/L (normal range: 9.5–29.8 µmol/L),
UIBC 78.1 µmol/L, TIBC 86.6 µmol/L, ferritin 11 µg/L (N
15–332 µg/L). SaO2 96% (pulse oxymeter). 2,3-diphos-
phoglycerate 5.7 mmol/l (N <5.5 mmol/L). Serum eryth-
ropoietin levels were from 23.2 to max. 72 mU/mL.
Erythropoietin level after phlebotomy was 55 mU/mL.
Tests of coagulation and platelet function were between
referent values. Bone marrow cytology and histology
were normal. Serum level of 2,3-diphosphoglycerate was
normal, and so was hemoglobin electrophoresis. Abdomi-
nal ultrasound, CT scan of the abdomen and brain as
well as isotopic renogram were within normal limits.
Family members (parents and sister) had normal red
blood counts.
As already recently reported, DNA analysis showed
homozygosity for 571CG (H191D) von Hippel-Lindau
tumor-suppressor gene (VHL) mutation, the first exam-
ple of homozygous VHL germline mutation causing poly-
cythemia other than the VHL 598CT mutation4.
During clinical observation the patient had no signifi-
cant medical problem. He reported headaches and concen-
tration difficulties when his hematocrit was high (Hct
0.60, Hgb200 g/L, E9.0x1012/L), and these symptoms
were immediately relieved by isovolemic phlebotomy.
Because of the slightly decreased values of serum iron
and ferritin the patient was administered iron supple-
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mentation therapy and aspirin. He had normal gastroin-
testinal iron absorption as well as intestinal permeability
testing.
During the next 12 months phlebotomy was required
on seven occasions. On iron supplementation, his serum
iron concentration increased, ranging between 6.1 and
17 µmol/L.
At one year, his hematology findings were found to
have considerably improved. Hct levels were 0.51–0.56
and Hgb concentration 144–159 g/L, while serum iron
concentration decreased to 2.3–4.9 µmol/L and ferritin to
1.8–5 ng/L (Figure 1). The reticulocytes count in that
time was up to 0,020. The patient admitted he had dis-
continued iron supplementation and made decision to re-
duce intake of iron by food, so he started diet without an-
imal protein and iron rich vegetables. We realized soon
that hematocrit would not reach high values to require
phlebotomy anymore. Over the next four years, the pa-
tient did not take iron supplementation. After with-
drawal of iron supplementation, his Hct value was 0.58
on a single occasion. The high values of Hct (0.60– 0.68)
that previously were regularly recorded have not been
observed since; the boy is free from any medical problem
and has not required new phlebotomy.
When last seen in May 2004, his Hct was 0.52 and he
had no complaints, and still without impact on neurologi-
cal or cognitive function. He is now 19 years old and a
successful university student and active tennis player.
His height is 180 cm, weight 69 kg, blood pressure 95/70
mmHg, c/p 76/min.
Conclusion
We present the patient with congenital polycythemia
in whom the frequency of phlebotomy has been kept
lower by obviating iron supplementation than when iron
was administered. We find that Swedish authors had a
similar outcome with patients with polycythemia vera5.
Our outcome suggests that if iron supplementation is
avoided, the frequency of phlebotomy can be kept lower
than when iron is administered in patients with congeni-
tal polycythemia.
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Fig. 1. Correlation between hematocrit and serum iron in our patient. Phlebotomy is pointed with .
T. F. Hajn`i}
Department of Pediatrics, Hematology Oncology Unit, University Hospital »Sestre milosrdnice«, Vinogradska 29,
10000 Zagreb, Croatia
e-mail: tomislav-franjo.hajnzic@zg.htnet.hr
KLINI^KI PRIKAZ PACIJENTA S KONGENITALNOM POLICITEMIJOM
S A @ E T A K
Autori prikazuju devetnaestogodi{njeg bolesnika, pra}enog unazad sedam godina, sa izoliranom apsolutnom eritro-
citozom i sideropenijom u kojeg je isklju~ena policitemija vera kao i ostali uzroci eritrocitoze. Policitemija je posljedica
nedavno opisane von Hippel-Lindau (VHL) mutacije. Prestankom terapije `eljezom prestala je potreba za flebotomijom
kod ovog bolesnika.
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